C. Michael Gibson, MD, MS

Articles by C. Michael Gibson, MD, MS

Patient Case No. 2

ByManesh R. Patel, MD,Payal Kohli, MD, FACC,John M. Flack, MD, MPH, FASH,C. Michael Gibson, MD, MS

January 8th 2025

Panelists discuss how chronic kidney disease (CKD) and uncontrolled hypertension create a damaging cycle, in which hypertension accelerates kidney damage while declining kidney function makes blood pressure harder to control.

Patient Case No. 1

ByManesh R. Patel, MD,Payal Kohli, MD, FACC,John M. Flack, MD, MPH, FASH,C. Michael Gibson, MD, MS

January 1st 2025

Panelists discuss how evaluating uncontrolled hypertension in patients with early kidney dysfunction requires a careful investigation of underlying causes, including medication adherence, lifestyle factors, and potential secondary hypertension.

Tips for Precise Readings

ByManesh R. Patel, MD,Payal Kohli, MD, FACC,John M. Flack, MD, MPH, FASH,C. Michael Gibson, MD, MS

January 1st 2025

Panelists discuss how proper blood pressure measurement techniques require careful attention to patient positioning, cuff size selection, and standardized procedures to ensure accurate readings.

Hypertension in Pregnancy and Women

ByManesh R. Patel, MD,Payal Kohli, MD, FACC,John M. Flack, MD, MPH, FASH,C. Michael Gibson, MD, MS

December 25th 2024

A panelist discusses how hypertensive disorders during pregnancy remain a leading cause of maternal mortality worldwide, affecting 5-10% of pregnancies and requiring careful monitoring, early detection, and appropriate medical management to protect both mother and baby.

PRECISION trial

ByManesh R. Patel, MD,Payal Kohli, MD, FACC,John M. Flack, MD, MPH, FASH,C. Michael Gibson, MD, MS

December 25th 2024

Panelists discuss how the PRECISION trial evaluated aprocitentan, a dual endothelin receptor antagonist (ERA), in patients with resistant hypertension taking 3 antihypertensive medications including a diuretic.

Endothelin Pathway

ByManesh R. Patel, MD,Payal Kohli, MD, FACC,John M. Flack, MD, MPH, FASH,C. Michael Gibson, MD, MS

December 18th 2024

Panelists discuss how the endothelin pathway critically regulates blood pressure and vascular health through the interplay between vasodilators and vasoconstrictors such as endothelin-1, representing a key mechanism in hypertension pathophysiology.

Current Therapeutic Guidelines for Managing Resistant Hypertension

ByManesh R. Patel, MD,Payal Kohli, MD, FACC,John M. Flack, MD, MPH, FASH,C. Michael Gibson, MD, MS

December 18th 2024

Panelists discuss how resistant hypertension management requires a structured approach combining lifestyle modifications, optimal doses of multiple drug classes, and the identification of underlying causes such as sleep apnea.

Difficult-to-Treat Hypertension Treatment Strategies

ByManesh R. Patel, MD,Payal Kohli, MD, FACC,John M. Flack, MD, MPH, FASH,C. Michael Gibson, MD, MS

December 11th 2024

Panelists discuss how antihypertensive treatment encompasses multiple drug classes with distinct mechanisms of action, alongside lifestyle modifications such as dietary changes and exercise, providing a comprehensive approach to blood pressure management.

Drug Classes Available to Treat Patients With High Blood Pressure

ByManesh R. Patel, MD,Payal Kohli, MD, FACC,John M. Flack, MD, MPH, FASH,C. Michael Gibson, MD, MS

December 11th 2024

Current Limitations With Traditional Antihypertensive Drugs

ByManesh R. Patel, MD,Payal Kohli, MD, FACC,John M. Flack, MD, MPH, FASH,C. Michael Gibson, MD, MS

December 4th 2024

Panelists discuss how traditional antihypertensive medications face challenges including adverse reactions, complex dosing regimens, and variable efficacy across different patient populations, which can limit their therapeutic success.

Unmet Needs in HTN: Patient Adherence, Comorbid Conditions, and Prevalence

ByManesh R. Patel, MD,Payal Kohli, MD, FACC,John M. Flack, MD, MPH, FASH,C. Michael Gibson, MD, MS

December 4th 2024

Panelists discuss how poor medication adherence and comorbidities such as chronic kidney disease (CKD) contribute to uncontrolled hypertension despite the availability of numerous treatment options, highlighting key challenges in achieving effective blood pressure management.